| [1] |
ZHAO Fanfei, ZHENG Yang, NIU Tantan, HUANG Chun .
Research progress on adverse reactions of antibody drugs conjugate in non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 120-127.
|
| [2] |
Integrated Oncology Branch of Chinese Anti-cancer Association, Tumor Marker Committee of Chinese Anti-cancer Association .
Expert consensus on radiotherapy combined with immunotherapy for non-small cell lung cancer (2024 edition)
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 505-515.
|
| [3] |
YU Degang, JIA Junmei.
Research progress of fibrinogen as a predictor of curative effect and prognosis of lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 628-632.
|
| [4] |
FANG Liaoxin, KANG Xiaofeng, XUE Chunyuan, PAN Lu, CHEN Jiaxin, TANG Chuanhao, SUN Liying, XU Xiaojie, DU Yimeng .
Effects of Omicron variant XBB.. spike protein on biological function of human non-small cell lung cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(3): 271-276.
|
| [5] |
LIU Bin, GUO Shuliang.
Advances in immune checkpoint inhibitor therapy for advanced non?small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(2): 243-248.
|
| [6] |
LI Nan, LU Chenyang, ZHU Ani, YANG Dongcai, MA Qian, YAN Fengqi, JIA Weihong.
Effects of glycolysis in Gefitinib resistance in non⁃small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 50-55.
|
| [7] |
HE Shuang, TIAN Jin, Long Lin, ZHAO Lili, XIAO Jun.
Lung cancer screening and early diagnosis: advances from imaging to biomarkers
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 120-126.
|
| [8] |
ZHAO Chengshuai, GU Haijiang, ZHONG Weiming, WANG Wei.
Research progress of detection and treatment of EGFR exon 20 insertion mutant non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 711-716.
|
| [9] |
QIU Haiping, XIE Xiaoping, CHEN Tianqing.
A trend analysis of the incidence and mortality of lung cancer and an age-period-cohort model in China,1990—2019
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 537-542.
|
| [10] |
ZHONG Guohui, LIANG Ningsheng, JIANG Neng .
Research progress of neoadjuvant drug therapy for non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(4): 435-443.
|
| [11] |
LIU Huaying, XIA Xue, ZHANG Mengwei, LUO Qinqin.
Bisdemethoxycurcumin induces apoptosis and inhibits proliferation of non-small cell lung cancer cells by regulating HIF-1α-mediated senescence
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 291-297.
|
| [12] |
ZHAO Guangqiang, XUE Tianhui, YAN Bing .
The value of the ratio of pre-operative platelet distribution width to tumor size in the prognosis of patients with non-metastatic lung adenocarcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 317-321.
|
| [13] |
GONG Jingjie, ZHANG Haibo, YANG Yi, CAO Jiayu, DING Nan, ZHAO Jun.
Influencing factors of quality of life in patients with advanced non-small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 322-327.
|
| [14] |
MA Haijun, SHANG Chunxiang, HAN Na, LI Miao.
Effect of miR-93-5p targeting PKMYT1 on the proliferation,migration and invasion of lung adenocarcinoma A549 cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 156-162.
|
| [15] |
SUN Man, LI Xiaomin.
New advances in the treatment of MET 14 exon skipping mutation in advanced non small cell lung cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 239-244.
|
